JPMorgan Chase & Co’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$124K Sell
173,477
-127,930
-42% -$91.3K ﹤0.01% 4706
2025
Q1
$196K Buy
301,407
+237,362
+371% +$154K ﹤0.01% 4443
2024
Q4
$118K Buy
64,045
+5,109
+9% +$9.4K ﹤0.01% 4719
2024
Q3
$204K Buy
58,936
+694
+1% +$2.4K ﹤0.01% 4454
2024
Q2
$171K Buy
58,242
+9,500
+19% +$27.8K ﹤0.01% 4347
2024
Q1
$275K Sell
48,742
-17,398
-26% -$98.3K ﹤0.01% 4287
2023
Q4
$284K Sell
66,140
-10,684
-14% -$45.8K ﹤0.01% 4211
2023
Q3
$267K Buy
76,824
+2,115
+3% +$7.34K ﹤0.01% 4064
2023
Q2
$347K Buy
74,709
+3,040
+4% +$14.1K ﹤0.01% 3959
2023
Q1
$332K Sell
71,669
-116,109
-62% -$538K ﹤0.01% 4041
2022
Q4
$1.52M Buy
187,778
+32,201
+21% +$260K ﹤0.01% 3132
2022
Q3
$864K Sell
155,577
-854
-0.5% -$4.74K ﹤0.01% 3451
2022
Q2
$815K Sell
156,431
-14,335
-8% -$74.7K ﹤0.01% 3604
2022
Q1
$1.4M Buy
170,766
+114,610
+204% +$942K ﹤0.01% 3413
2021
Q4
$836K Sell
56,156
-563
-1% -$8.38K ﹤0.01% 3787
2021
Q3
$1.07M Sell
56,719
-6,429
-10% -$121K ﹤0.01% 3561
2021
Q2
$1.17M Buy
63,148
+4,061
+7% +$75.5K ﹤0.01% 3545
2021
Q1
$1.35M Sell
59,087
-7,510
-11% -$171K ﹤0.01% 3467
2020
Q4
$1.45M Sell
66,597
-5,815
-8% -$126K ﹤0.01% 3165
2020
Q3
$745K Sell
72,412
-10,060
-12% -$104K ﹤0.01% 3217
2020
Q2
$640K Sell
82,472
-19,401
-19% -$151K ﹤0.01% 3204
2020
Q1
$1.04M Sell
101,873
-1,545
-1% -$15.7K ﹤0.01% 2930
2019
Q4
$1.14M Buy
103,418
+4,876
+5% +$53.7K ﹤0.01% 2991
2019
Q3
$896K Buy
98,542
+3,503
+4% +$31.9K ﹤0.01% 3115
2019
Q2
$1.08M Sell
95,039
-821
-0.9% -$9.31K ﹤0.01% 3026
2019
Q1
$1.09M Sell
95,860
-3,591
-4% -$40.9K ﹤0.01% 2982
2018
Q4
$898K Sell
99,451
-599
-0.6% -$5.41K ﹤0.01% 3094
2018
Q3
$1.5M Buy
+100,050
New +$1.5M ﹤0.01% 2947